{"id":12447,"date":"2009-07-04T18:00:00","date_gmt":"2009-07-04T18:00:00","guid":{"rendered":""},"modified":"2017-10-26T13:58:40","modified_gmt":"2017-10-26T13:58:40","slug":"nutukimo-itaka-susirgti-onkologine-liga","status":"publish","type":"post","link":"https:\/\/www.pasveik.lt\/lt\/naujausi-medicinos-straipsniai\/nutukimo-itaka-susirgti-onkologine-liga\/12447\/","title":{"rendered":"Nutukimo \u012ftaka susirgti onkologine liga"},"content":{"rendered":"<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Dainora Butkut\u0117<\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Kauno medicinos universitetas<\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><i><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Ekonomi\u0161kai stiprioms valstyb\u0117ms vis aktualesn\u0117 darosi ne bado, o nutukimo problema. \u0160iuo metu pasaulyje 2 milijardai gyventoj\u0173 turi antsvorio ar yra nutuk\u0119, i\u0161 j\u0173 net 10 proc. vaik\u0173 ir paaugli\u0173. Mokslininkai prana\u0161auja, jog 2030 metais nutukusi\u0173 \u017emoni\u0173 bus net 43 proc., vadinasi, kas antras pasaulio gyventojas [21]. Supratus netinkamos mitybos pra\u017e\u016btingum\u0105, b\u016bt\u0173 galima i\u0161vengti jos padarini\u0173.<\/span><\/i><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">\u00a0\u00a0<\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Riba tarp sveikos ir \u017ealingos mitybos<\/span><\/b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\"><\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Maitinimasis \u2013 tai gyvybi\u0161kai svarbus pirminis fiziologinis poreikis, kur\u012f b\u016btina tenkinti. Maisto pramon\u0117 labai i\u0161tobul\u0117jusi ir si\u016blo itin plat\u0173 asortiment\u0105. Da\u017enai sud\u0117tinga nuspr\u0119sti, kuo produktai skiriasi, kuris sveikesnis, nat\u016bralesnis. Siekiant apsaugoti vartotojus nuo ydingos, klaidinan\u010dios reklamos 1992 metais sukurta ir visuomenei pateikta sveikos mitybos piramid\u0117. Remiantis dietolog\u0173 rekomendacijomis, pagal \u0161i\u0105 piramid\u0119 savo racion\u0105 formuoti galima vis\u0105 gyvenim\u0105 \u2013 vitamin\u0173, mineralini\u0173 med\u017eiag\u0173, kit\u0173 organizmui b\u016btin\u0173 med\u017eiag\u0173 gausime pakankamai. Svarbu atkreipti d\u0117mes\u012f, kad kiekvienas maisto produktas yra naudingas organizmui, ta\u010diau svarbiausias sveikos ir \u017ealingos mitybos skirtumas \u2013 netinkamas kiekis. Mitybos piramid\u0117 tiksliai nenurodo, kiek koki\u0173 produkt\u0173 tur\u0117tume suvalgyti, ta\u010diau padeda suprasti \u012fvairi\u0173 produkt\u0173 optimal\u0173 santyk\u012f. Svarbu ne tik tinkamai maitintis, bet ir neapleisti savo k\u016bno fizi\u0161kai. Sveikai gyvenantiems b\u016btina sportuoti, mank\u0161tintis, palaikyti sveik\u0105 k\u016bno mas\u0119 [1]. <\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Maisto pried\u0173 \u012fvairov\u0117. J\u0173 reik\u0161m\u0117<\/span><\/b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\"><\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Pagrindinis sveikos mitybos principas \u2013 \u012fvairov\u0117s. Maisto asortimentas turi b\u016bti \u012fvairus, produktus b\u016btina rinktis i\u0161 vis\u0173 piramid\u0117s auk\u0161t\u0173. Labai svarbu atkreipti d\u0117mes\u012f \u012f tai, kokius produktus vartojame: konservuotus, \u0161vie\u017eius, \u0161aldytus, gazuotus, \u012fvairiaspalvius. Ant kiekvienos maisto produkto pakuot\u0117s rasime \u012fvairi\u0173 maisto pried\u0173 s\u0105ra\u0161\u0105, kuriais siekiama prek\u0119 ilgesn\u012f laik\u0105 i\u0161laikyti skanesn\u0119, kvapesn\u0119, \u0161vie\u017eesn\u0119. \u0160ie priedai \u017eymimi E raide (nuo \u017eod\u017eio \u201eEurope\u201c) ir skirstomi \u012f kelet\u0105 grupi\u0173: da\u017eikliai, konservantai, antioksidantai, saldikliai, tir\u0161tikliai, skaidrikliai ir kiti. Vis\u0173 maisto pried\u0173 poveikis organizmui yra tiriamas, taip su\u017einoma apie galim\u0105 j\u0173 kenksmingum\u0105. Jei maisto priedas gali sukelti nepageidaujam\u0105 poveik\u012f, jis priskiriamas prie pavojing\u0173 vartoti maisto pried\u0173 ar net u\u017edraud\u017eiamas. Dalis maisto pried\u0173, kurie yra naudojami maisto pramon\u0117je gali skatinti formuotis navikus. Tai \u2013 kancerogeniniai maisto priedai. Kancerogeniniai maisto priedai link\u0119 kauptis, tad nuolatinis j\u0173 vartojimas dideliais kiekiais gali b\u016bti itin \u017ealingas (1 lentel\u0117) [2, 3]. <\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">1 lentel\u0117. <\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">Maisto priedai, keliantys pavoj\u0173 sveikatai<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\"><\/span><\/p>\n<table style=\"width: 433.5pt; mso-cellspacing: 0cm; border: 1.5pt outset;\" border=\"1\">\n<tbody>\n<tr style=\"height: 1.5pt;\">\n<td style=\"width: 433.5pt; height: 1.5pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\" colspan=\"2\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">Liga<span style=\"mso-spacerun: yes;\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span>Maisto priedas<a name=\"0.1_table01\"><\/a><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 2.25pt;\">\n<td style=\"width: 163.5pt; height: 2.25pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">Didina v\u0117\u017eini\u0173 lig\u0173 rizik\u0105<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<td style=\"width: 270pt; height: 2.25pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">E 131, E 142, E 210\u2013217,\u00a0 E 239, E 249, E 250\u2013252, E 330, E 320, E 330, E 954<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 0.75pt;\">\n<td style=\"width: 163.5pt; height: 0.75pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">Didina cholesterolio koncentracij\u0105 kraujyje<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<td style=\"width: 270pt; height: 0.75pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">E 320, E 321<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 0.75pt;\">\n<td style=\"width: 163.5pt; height: 0.75pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">Didina kraujo spaudim\u0105 \u00a0\u00a0\u00a0\u00a0 <\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<td style=\"width: 270pt; height: 0.75pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">E 250, E 251, E 252<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 0.75pt;\">\n<td style=\"width: 163.5pt; height: 0.75pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">Pavojingi vartoti<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<td style=\"width: 270pt; height: 0.75pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">E 102, E 110, E 120, E 124, E 127<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 1.5pt;\">\n<td style=\"width: 163.5pt; height: 1.5pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">Labai pavojingi <\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<td style=\"width: 270pt; height: 1.5pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">E 123<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 2.25pt;\">\n<td style=\"width: 163.5pt; height: 2.25pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">U\u017edrausti vartoti\u00a0 <\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<td style=\"width: 270pt; height: 2.25pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">E 103, E 105, E 111, E 121, E 125, E 126, E 130, E 152, E 181<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">\u00a0<\/span><b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">K\u016bno mas\u0117s \u012fvertinimas<\/span><\/b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\"><\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Siekiant objektyviai \u012fvertinti k\u016bno mas\u0119, taikomas k\u016bno mas\u0117s indeksas (KMI), kuris rodo normal\u0173 k\u016bno svor\u012f, antsvor\u012f ar nutukim\u0105. KMI apskai\u010diuojamas svor\u012f (kg) padalijus i\u0161 \u016bgio (m), pakelto kvadratu. Gautas skai\u010dius, atsi\u017evelgiant \u012f\u00a0<a href=\"http:\/\/www.gastroklinika.lt\/nutukimo-operacijos\/\" target=\"_blank\">KMI<\/a> intervalus, rodo, kokia yra k\u016bno mas\u0117 (2 lentel\u0117) [4, 22].<\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">2 lentel\u0117. K\u016bno mas\u0117s indeksas<\/span><\/p>\n<table style=\"width: 204pt; mso-cellspacing: 0cm; border: 1.5pt outset;\" border=\"1\">\n<tbody>\n<tr style=\"height: 9.75pt;\">\n<td style=\"background: #fee6d2; height: 9.75pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><b style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">KMI (kg\/m\u00b2)<a name=\"0.1_table02\"><\/a><\/span><\/b><\/p>\n<\/td>\n<td style=\"background: #fee6d2; height: 9.75pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><b style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">K\u016bno svoris<\/span><\/b><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 9pt;\">\n<td style=\"background: #fee6d2; height: 9pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">&lt; 18,5<\/span><\/p>\n<\/td>\n<td style=\"background: #fee6d2; height: 9pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">Per ma\u017eas<\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 9.75pt;\">\n<td style=\"background: #fee6d2; height: 9.75pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">18,5\u201324,9<\/span><\/p>\n<\/td>\n<td style=\"background: #fee6d2; height: 9.75pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">Normalus <\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 9pt;\">\n<td style=\"background: #fee6d2; height: 9pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">25\u201329,9\u00a0 <\/span><\/p>\n<\/td>\n<td style=\"background: #fee6d2; height: 9pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">Antsvoris<\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 9.75pt;\">\n<td style=\"background: #fee6d2; height: 9.75pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">30\u201334,9 <\/span><\/p>\n<\/td>\n<td style=\"background: #fee6d2; height: 9.75pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">I<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: 'MS Mincho';\">\u2070<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"> <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/nutukimas\/4355\">nutukimas<\/a><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 9pt;\">\n<td style=\"background: #fee6d2; height: 9pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">35\u201339,9 <\/span><\/p>\n<\/td>\n<td style=\"background: #fee6d2; height: 9pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">II<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: 'MS Mincho';\">\u2070<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"> <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/nutukimas\/4355\">nutukimas<\/a><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 9.75pt;\">\n<td style=\"background: #fee6d2; height: 9.75pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">&gt; 40,0<\/span><\/p>\n<\/td>\n<td style=\"background: #fee6d2; height: 9.75pt; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">III<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-fareast-font-family: 'MS Mincho';\">\u2070<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"> <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/nutukimas\/4355\">nutukimas<\/a><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"line-height: 150%; text-align: justify;\"><b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Ar yra ry\u0161ys tarp svorio ir onkologini\u0173 lig\u0173<\/span><\/b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\"><\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Remiantis \u012fvairi\u0173 mokslini\u0173 tyrim\u0173 duomenimis galima dr\u0105siai teigti: k\u016bno mas\u0117 susijusi su onkologin\u0117mis ligomis. Apie 10 proc. vis\u0173 mir\u010di\u0173 nuo v\u0117\u017eio lemia <a href=\"https:\/\/pasveik.lt\/ligos\/&lt;a href=\">nutukimas<\/a>\/4355&#8243;&gt;nutukimas (ner\u016bkan\u010di\u0173j\u0173 grup\u0117je) [5, 22]. Antsvoris\/<a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/nutukimas\/4355\">nutukimas<\/a> turi \u012ftakos stempl\u0117s, skydliauk\u0117s, kr\u016bties, inkst\u0173, tul\u017eies p\u016bsl\u0117s, gimdos gleivin\u0117s ir kit\u0173 organ\u0173 piktybini\u0173 lig\u0173 patogenezei (3 lentel\u0117 ) [6, 7, 8, 9]. Rizika susirgti \u012fvairi\u0173 tip\u0173 karcinomomis priklauso nuo keleto veiksni\u0173: lyties, am\u017eiaus, gyvensenos [7, 8, 9]. Mechanizmai vis dar n\u0117ra tiksliai \u017einomi, ta\u010diau nustatyta, kad kr\u016bties v\u0117\u017eio vystymuisi \u012ftakos turi padid\u0117j\u0119s estrogen\u0173 kiekis, kur\u012f s\u0105lygoja didelis adipocit\u0173 paplitimas, gaubtin\u0117s \u017earnos v\u0117\u017eio \u2013 nuolatin\u0117 hiperinsulinemija, kuri\u0105 sukelia <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/nutukimas\/4355\">nutukimas<\/a> [10, 11, 12]. Ta\u010diau akivaizdu, jog kontroliuojant svor\u012f galima suma\u017einti ir v\u0117\u017eini\u0173 lig\u0173. <\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">3 lentel\u0117. <\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">V\u0117\u017eio rizikos padid\u0117jimas<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\"> esant per didelei k\u016bno masei<\/span><\/p>\n<table style=\"width: 602px; height: 232px; mso-cellspacing: 0cm; border: 1.5pt outset;\" border=\"1\">\n<tbody>\n<tr style=\"height: 1.5pt;\">\n<td style=\"height: 1.5pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\" colspan=\"2\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\">\u00a0<span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 1.5pt;\">\n<td style=\"height: 1.5pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><strong><span style=\"font-size: 10pt; font-family: Arial;\">Vyrams (5 kg\/m\u00b2 antsvoris) <\/span><\/strong><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<td style=\"height: 1.5pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><strong><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-weight: bold;\">Moterims (5 kg\/m\u00b2 antsvoris) <\/span><\/strong><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 2.25pt;\">\n<td style=\"height: 2.25pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">Stempl\u0117s adenokarcinomos\u201352 proc. <\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<td style=\"height: 2.25pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">Stempl\u0117s adenokarcinomos \u2013 51 proc. <\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 1.5pt;\">\n<td style=\"height: 1.5pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">Skydliauk\u0117s \u2013 32 proc. <\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<td style=\"height: 1.5pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">Tul\u017eies p\u016bsl\u0117s \u2013 59 proc.<\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 1.5pt;\">\n<td style=\"height: 1.5pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">Gaubtin\u0117s \u017earnos \u2013 24 proc. <\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<td style=\"height: 1.5pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">Gimdos gleivin\u0117s \u2013 59 proc. <\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 1.5pt;\">\n<td style=\"height: 1.5pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\">Inkst\u0173 \u2013 24 proc. <\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<td style=\"height: 1.5pt; background-color: transparent; border: #c0c0c0; padding: 0.75pt;\">\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial;\"><a name=\"0.1_graphic06\"><\/a>Inkst\u0173 \u2013 34 proc. <\/span><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"line-height: 150%; text-align: justify;\"><b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Mechanizmas, kaip k\u016bno svoris didina v\u0117\u017eio rizik\u0105 <\/span><\/b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\"><\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Gaunamos energijos perteklius \u2013 svarbus rizikos veiksnys v\u0117\u017eiui formuotis. \u0160is teiginys yra pagr\u012fstas \u012fvairiais tyrimais, kuriais \u012frodyta, kad suma\u017einus gaunamos energijos kiek\u012f suma\u017e\u0117ja ir rizika susirgti viena ar kita v\u0117\u017eine liga. Galimi keli fiziologiniai mechanizmai, kuriais ai\u0161kintinas toks ry\u0161is. D\u0117l padid\u0117jusio riebalinio audinio kiekio:<\/span><\/p>\n<ul>\n<li class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l3 level1 lfo1;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">padaug\u0117ja aktyvi\u0173 deguonies radikal\u0173, oksiduotos DNR pa\u017eaid\u0173; <\/span><\/li>\n<li class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l3 level1 lfo1;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">pakinta kancerogenini\u0173 ferment\u0173 metabolizmas; <\/span><\/li>\n<li class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: list 36.0pt; mso-list: l3 level1 lfo1;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">sutrinka l\u0105stel\u0117s gyvenimo ciklas, proliferacija, diferenciacija, apoptoz\u0117. <\/span><\/li>\n<\/ul>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Visi \u0161ie veiksniai gali lemti naviko prad\u017ei\u0105 ir progresavim\u0105 [6]. <\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">D\u0117l adipocit\u0173 pertekliaus sutrinka insulino, insulino augimo faktoriaus-1 (toliau IAF-1 ), lytini\u0173 hormon\u0173 apykaita. \u0160ie veiksniai reguliuoja l\u0105steli\u0173 diferenciacij\u0105, proliferacij\u0105, apoptoz\u0119. Kai j\u0173 per daug, nevyksta apoptoz\u0117, l\u0105stel\u0117s intensyviai ve\u0161a, auga ir taip galiausiai lemia naviko atsiradim\u0105. D\u0117l adipocit\u0173 pertekliaus daugiau i\u0161siskiria laisv\u0173j\u0173 riebal\u0173 r\u016bg\u0161\u010di\u0173, naviko nekroz\u0117s alfa faktoriaus, rezistino ir suma\u017e\u0117ja adiponektino koncentracija \u2013 tai lemia atsparum\u0105 insulinui. D\u0117l hiperinsulinemijos suma\u017e\u0117ja IAF-1 prijungian\u010di\u0173 baltym\u0173 sintez\u0117 ir sekrecija, o tai s\u0105lygoja didesn\u012f kiek\u012f aktyvi\u0173 IAF-1. Insulino molekul\u0117s kartu su IAF-1 jungiasi prie l\u0105steli\u0173 taikini\u0173 receptori\u0173 ir, slopindami apoptoz\u0119, skatina l\u0105steli\u0173 proliferacij\u0105. Pana\u0161\u016bs poky\u010diai esant antsvoriui ar nutukimui vyksta ir hormon\u0173 gamyboje. D\u0117l hiperinsulinemijos ma\u017eiau sintetinama lytinius hormonus prijungian\u010di\u0173 baltym\u0173, o d\u0117l adipocit\u0173 pertekliaus daugiau susidaro testosterono ir estradiol\u0173. \u0160i\u0173 lytini\u0173 hormon\u0173 perteklius veikia kr\u016bties, gimdos, prostatos l\u0105steles taikinius: sutrikdo j\u0173 gyvenimo cikl\u0105. D\u0117l \u0161i\u0173 poky\u010di\u0173 formuojasi \u012fvairi\u0173 sistem\u0173 navikai [20, 23].\u00a0 <\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;\"><b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">Stempl\u0117s v\u0117\u017eys<\/span><\/b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"> <\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Tyrim\u0173 duomenimis, stempl\u0117s v\u0117\u017eio (adenokarcinomos ) atvej\u0173 JAV per pastaruosius keliasde\u0161imt met\u0173 padaug\u0117jo itin \u017eenkliai. 1973 m. u\u017efiksuoti 300 t\u016bkst. nauj\u0173 atvej\u0173, o\u00a0 2001m. \u2013 net 2 mln. 100 t\u016bkst. [13, 14]. Tai paai\u0161kinama pasikeitusiais mitybos \u012fpro\u010diais \u2013 tapo itin madinga valgyti daug angliavandeni\u0173 turin\u010dio maisto, kuris neigiamai veikia stempl\u0117s gleivin\u0119. Prie \u0161io rizikos veiksnio prisideda ir epidemi\u0161kai plintantis gastroezofaginis refliuksas, kuriam pasireik\u0161ti taip pat \u012ftakos turi mitybos \u012fpro\u010diai [15]. Tyrimai skelbia, jog <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/nutukimas\/4355\">nutukimas<\/a> net \u0161e\u0161is kartus padidina rizik\u0105 susirgti \u0161ios lokalizacijos v\u0117\u017eiu, ypa\u010d vyrams nuo 50 met\u0173 [15]. JAV adenokarcinoma yra a\u0161tunta pagal da\u017enum\u0105 mirties prie\u017eastis, taigi ma\u017einant antsvorio turin\u010di\u0173 ir nutukusi\u0173 \u017emoni\u0173 skai\u010di\u0173, reik\u0161mingai suma\u017e\u0117t\u0173 ir mir\u010di\u0173. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto; tab-stops: 258.5pt;\"><b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">Lyties organ\u0173 <a href=\"http:\/\/www.gastroklinika.lt\/paslaugos\/onkologines-operacijos\/\" target=\"_blank\">navikai<\/a><\/span><\/b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">\u00a0<span style=\"mso-tab-count: 1;\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><b style=\"mso-bidi-font-weight: normal;\"><i style=\"mso-bidi-font-style: normal;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Kr\u016bties ir gimdos gleivin\u0117s v\u0117\u017eys<\/span><\/i><\/b><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">1970 metais pirm\u0105 kart\u0105 pasteb\u0117tas ry\u0161ys tarp padid\u0117jusios k\u016bno mas\u0117s ir kr\u016bties v\u0117\u017eio [10]. Daugybe tyrim\u0173 m\u0117ginta i\u0161siai\u0161kinti, kaip rizika skiriasi ikimenopauzinio ir pomenopauzinio am\u017eiaus moterims. Tyrim\u0173 duomenimis, jaunesnio am\u017eiaus moterims rizika susirgti kr\u016bties v\u0117\u017eiu ma\u017eesn\u0117, net jei KMI didesnis nei 25 kg\/m\u00b2, palyginti su moterims po menopauz\u0117s. \u0160iuo tarpsniu rizika padid\u0117ja 20\u201340 proc. (\u012fvairi\u0173 tyrim\u0173 i\u0161vados skiriasi). <\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Tyrimais nustatytas ry\u0161ys ir tarp gimdos gleivin\u0117s bei nutukimo. Bet kurio am\u017eiaus moterims rizika juo susirgti yra vienoda, ne taip kaip kr\u016bties v\u0117\u017eiu [6]. \u012edomu atkreipti d\u0117mes\u012f \u012f tai, kad 9\u201322,5 kg antsvoris rizik\u0105 padidina tik 3 kartais, o daugiau kaip 22,5 kg \u2013 net 10 kart\u0173 [16]. Esama duomen\u0173, kad moterims, kurioms lytinius hormonus prijungian\u010dio baltymo koncentracija suma\u017e\u0117jusi, o estrogen\u0173 ir progesteron\u0173 \u2013 padid\u0117jusi koncentracija, rizika susirgti irgi didesn\u0117 [6]. Tyrimo duomenimis, rizika padid\u0117ja pomenopauzinio am\u017eiaus moterims vartojat pakei\u010diamuosius estrogenus, o vaisingo \u2013geriamuosius kontraceptikus (16 dien\u0173 estrogenus ir 10 dien\u0173 progesteronus). Pakei\u010diamieji hormon\u0173 preparatai, kuriuos sudaro ir estrogenai, ir progesteronai, \u012ftakos susirgti gleivin\u0117s v\u0117\u017eiu neturi [6].\u00a0 \u00a0<\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><b style=\"mso-bidi-font-weight: normal;\"><i style=\"mso-bidi-font-style: normal;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Prostatos v\u0117\u017eys<\/span><\/i><\/b><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">D\u0117l nutukimo \u012ftakos prostatos v\u0117\u017eio vystymuisi bendros nuomon\u0117s n\u0117ra. Vieni tyrimai rodo, kad riebalinio audinio kiekis neturi jokios \u012ftakos, kiti \u2013 kad \u012ftakos turi riebalinio audinio pasiskirstymas, \u016bgis ir k\u016bno mas\u0117 jauname am\u017eiuje [6]. Ta\u010diau esama tyrim\u0173, kurie \u0161i\u0105 hipotez\u0119 paneigia [18]. <\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">JAV atliktu tyrimu nustatyta, kad prostatos v\u0117\u017eiu susirgusiems vyrams, kurie turi antsvorio ar yra nutuk\u0119, po gydymo rizika mirti yra 2 kartus didesn\u0117 nei normalaus svorio vyrams [17]. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;\"><b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">Storosios \u017earnos v\u0117\u017eys<\/span><\/b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"> <\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Tiksli\u0173 tyrim\u0173 duomen\u0173, \u012frodan\u010di\u0173 nutukimo ir storosios \u017earnos v\u0117\u017eio ry\u0161\u012f vis dar n\u0117ra, ta\u010diau tokia hipotez\u0117 i\u0161kelta ir tikrinama \u012fvairios apimties tyrimais. Kai kurie j\u0173 rodo, kad <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/nutukimas\/4355\">nutukimas<\/a> yra reik\u0161mingiausias storosios \u017earnos v\u0117\u017eio rizikos veiksnys [11, 12].\u00a0 Viename tyrim\u0173 tirtos 40\u201359 am\u017eiaus moterys (n = 90 t\u016bkst.). Per de\u0161imt tyrimo met\u0173 buvo nustatyti 527 storosios \u017earnos v\u0117\u017eio atvejai. Pateikiama i\u0161vada, kad ikimenopauzinio am\u017eiaus nutukusioms moterims rizika susirgti \u0161ios lokalizacijos v\u0117\u017eiu yra dvigubai didesn\u0117 nei sveiko svorio moterims. Po menopauz\u0117s nutukusioms ir sveiko svorio moterims rizika yra apylyg\u0117. Manoma, kad padid\u0117jusi k\u016bno mas\u0117 lemia nuolatin\u0119 hiperinsulinemij\u0105, o \u0161i skatina v\u0117\u017einius poky\u010dius [11]. \u00a0 <\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;\"><b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"><a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/inkstu-vezys\/4516\">Inkst\u0173 v\u0117\u017eys<\/a><\/span><\/b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"> <\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Kalifornijos v\u0117\u017eio centro mokslininkai pasteb\u0117jo, kad galimas ry\u0161is tarp nutukimo ir inkst\u0173 v\u0117\u017eio. Nutuk\u0119 pacientai da\u017enai serga hipertenzija, o ji vienas svarbiausi\u0173 rizikos veiksni\u0173 inkst\u0173 l\u0105steli\u0173 navikams formuotis. <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/nutukimas\/4355\">Nutukimas<\/a> kartu su hipertenzija sukelia lipid\u0173 peroksidacij\u0105, kuri lemia inkst\u0173 l\u0105steli\u0173 DNR pa\u017eeidimus. \u0160ie pa\u017eeidimai s\u0105lygoja l\u0105steli\u0173 mutacijas, sutrikdo gyvyb\u0117s cikl\u0105. Jei organizmas negeba apsiginti ir i\u0161taisyti klaid\u0173, formuojasi navikas. Moterims \u0161i\u0105 rizik\u0105 dar padidina estrogen\u0173 perteklius, kuris taip pat susij\u0119s su nutukimu [19].\u00a0 <\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin: 0cm 0cm 0pt; line-height: 150%; text-align: justify; mso-margin-top-alt: auto; mso-margin-bottom-alt: auto;\"><b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\">Kit\u0173 lokalizacij\u0173 v\u0117\u017eys<\/span><\/b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt;\"> <\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Esama duomen\u0173 apie nutukimo ir kit\u0173 lokalizacij\u0173 navik\u0173 ry\u0161\u012f, ta\u010diau jis nustatytas tik pavieniais tyrimais ir tiksli\u0173 duomen\u0173 n\u0117ra. S\u0105saja galima su kasos, kiau\u0161id\u017ei\u0173, gimdos kaklelio, hematopoetin\u0117s sistemos navikais, ta\u010diau vis dar reikia papildom\u0173 tyrim\u0173 norint tiksli\u0173 i\u0161vad\u0173.<\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 13.5pt; mso-ansi-language: LT;\">Mirtingumas<\/span><\/b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\"><\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Jungtin\u0117se Amerikos Valstijose buvo atliktas did\u017eiulis tyrimas: dalyvavo 900 t\u016bkst. pacient\u0173 (404 576 vyrai ir 495 477 moterys). \u012e j\u012f \u012ftraukti asmenys nesirg\u0119 v\u0117\u017eiu, o per 16 steb\u0117jimo met\u0173 nuo v\u0117\u017eio mir\u0117 net 57 145 tiriamieji. Tyrimu siekta nustatyti ry\u0161\u012f tarp KMI ir mir\u0161tamumo nuo v\u0117\u017eio (tiriant tiek moteris, tiek vyrus), kiti galimi rizikos veiksniai buvo itin atid\u017eiai kontroliuojami. Nustatyta, kad pacient\u0173, kuri\u0173 KMI vir\u0161ijo 40 kg\/m\u00b2, nuo v\u0117\u017eio mir\u0117 daugiausia (vyrai \u2013 52 proc., moterys \u2013 62 proc.). Nustatyta, kad didelis KMI turi \u012ftakos susirgti stempl\u0117s, gaubtin\u0117s ir tiesiosios \u017earnos, kepen\u0173, tul\u017eies p\u016bsl\u0117s, kasos ir inkst\u0173 v\u0117\u017eiu. KMI buvo susij\u0119s ir su vyr\u0173 skrand\u017eio bei prostatos v\u0117\u017eiu ir su moter\u0173 kr\u016bties, kiau\u0161id\u017ei\u0173, gimdos kaklelio, gimdos v\u0117\u017eiu [9].\u00a0<\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 13.5pt; mso-ansi-language: LT;\">Ar tikrai tiesa<\/span><\/b><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\"><\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Neretai dvejojama, ar tikrai nutukusiems \u017emon\u0117ms rizika susirgti v\u0117\u017eiu didesn\u0117. Neabejotina nutukimo \u012ftaka \u012frodyta daugybe mokslini\u0173 tyrim\u0173, o tai svarbu profilaktikai: ji gali gerokai suma\u017einti v\u0117\u017eini\u0173 lig\u0173 skai\u010di\u0173. <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/nutukimas\/4355\">Nutukimas<\/a> yra paveikiamas veiksnys ir tai privalu tinkamai \u012fvertinti. Vaikai turi b\u016bti mokomi sveikos mitybos pagrind\u0173, kurie b\u016bt\u0173 taikomi dar\u017eeliuose, mokyklose, namuose. Labai svarbu ir suaugusiesiems r\u016bpintis savo mityba. B\u016btina daugiau, nei dabar esame \u012fprat\u0119, jud\u0117ti, da\u017eniau rinktis dvirat\u012f ar \u0117jim\u0105 p\u0117s\u010diomis, o ne automobil\u012f. Duomen\u0173 apie svorio suma\u017einimo nauda jau susirgus v\u0117\u017eiu ma\u017ea, tod\u0117l tinkama pirmin\u0117 profilaktika apsaugot\u0173 nuo dideli\u0173 b\u0117d\u0173 v\u0117liau.\u00a0\u00a0\u00a0<\/span><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><strong><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Lietuvos gydytojo \u017eurnalas<\/span><\/strong><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><strong><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\"><a href=\"https:\/\/pasveik.lt\/apie-mityba\/34484\">Testai apie sveik\u0105 mityb\u0105<\/a><\/span><\/strong><\/p>\n<p style=\"line-height: 150%; text-align: justify;\"><strong><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\"><a href=\"https:\/\/pasveik.lt\/dietos\/ligoniams\/mityba-sergant-cukriniu-diabetu\/35384\">Dietos<\/a><\/span><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p style=\"line-height: 150%; text-align: justify;\"><i><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">Ekonomi\u0161kai stiprioms valstyb\u0117ms vis aktualesn\u0117 darosi ne bado, o nutukimo problema. \u0160iuo metu pasaulyje 2 milijardai gyventoj\u0173 turi antsvorio ar yra nutuk\u0119, i\u0161 j\u0173 net 10 proc. vaik\u0173 ir paaugli\u0173. Mokslininkai prana\u0161auja, jog 2030 metais nutukusi\u0173 \u017emoni\u0173 bus net 43 proc., vadinasi, kas antras pasaulio gyventojas [21]. Supratus netinkamos mitybos pra\u017e\u016btingum\u0105, b\u016bt\u0173 galima i\u0161vengti jos padarini\u0173.<\/span><\/i><span style=\"font-size: 10pt; font-family: Arial; mso-bidi-font-size: 12.0pt; mso-ansi-language: LT;\">\u00a0\u00a0<\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[27342],"tags":[1750,431,6566,9855,791,157,893,1041,95],"site":[],"post_item_type":[27345],"class_list":["post-12447","post","type-post","status-publish","format-standard","hentry","category-stilius","tag-antsvoris","tag-hipertenzija","tag-lasteles","tag-lentele","tag-mases","tag-nutukimas","tag-pusles","tag-svoris","tag-vezys"],"acf":{"post_sites":false},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts\/12447","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/comments?post=12447"}],"version-history":[{"count":0,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts\/12447\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/media?parent=12447"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/categories?post=12447"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/tags?post=12447"},{"taxonomy":"site","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/site?post=12447"},{"taxonomy":"post_item_type","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/post_item_type?post=12447"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}